Stocks and Investing Stocks and Investing
Wed, July 12, 2017
[ 12:00 AM ] - WOPRAI
Jim Giannakouros Maintained (XYL) at Buy with Increased Target to $60 on, Jul 12th, 2017
Tue, July 11, 2017
[ 12:00 AM ] - WOPRAI
Sandeep Deshpande Upgraded (STM) to Buy on, Jul 11th, 2017
[ 12:00 AM ] - WOPRAI
Michael Dahl Downgraded (TPH) to Hold on, Jul 11th, 2017
[ 12:00 AM ] - WOPRAI
Michael Dahl Downgraded (TOL) to Sell on, Jul 11th, 2017
[ 12:00 AM ] - WOPRAI
Paul Cheng Upgraded (XOM) to Buy on, Jul 11th, 2017
[ 12:00 AM ] - WOPRAI
Raghuram Selvaraju Initiated (XRAY) at Strong Buy and Held Target at $74 on, Jul 11th, 2017
[ 12:00 AM ] - WOPRAI
Nigel Coe Initiated (WSO) at Hold on, Jul 11th, 2017
[ 12:00 AM ] - WOPRAI
Brian Nowak Downgraded (SNAP) to Hold on, Jul 11th, 2017
[ 12:00 AM ] - WOPRAI
Biren Amin Initiated (VRTX) at Strong Buy and Held Target at $155 on, Jul 11th, 2017
[ 12:00 AM ] - WOPRAI
Nigel Coe Initiated (SWK) at Buy and Held Target at $160 on, Jul 11th, 2017
[ 12:00 AM ] - WOPRAI
Jay Olson Upgraded (TXMD) to Buy on, Jul 11th, 2017
[ 12:00 AM ] - WOPRAI
William Power Initiated (TWLO) at Buy on, Jul 11th, 2017
[ 12:00 AM ] - WOPRAI
Lawrence De Maria Upgraded (AGCO) to Buy on, Jul 11th, 2017
[ 12:00 AM ] - WOPRAI
Nick Setyan Initiated (CAKE) at Buy and Held Target at $57 on, Jul 11th, 2017
[ 12:00 AM ] - WOPRAI
Alevizos Alevizakos Initiated (C) at Hold and Held Target at $71 on, Jul 11th, 2017
[ 12:00 AM ] - WOPRAI
Neena Bitritto-Garg Initiated (ANAB) at Buy and Held Target at $36 on, Jul 11th, 2017
[ 12:00 AM ] - WOPRAI
Eun Yang Initiated (BIIB) at Hold and Held Target at $310 on, Jul 11th, 2017
[ 12:00 AM ] - WOPRAI
Joanne Wuensch Upgraded (BAX) to Buy on, Jul 11th, 2017
Mon, July 10, 2017
[ 12:00 AM ] - WOPRAI
Stephen Byrd Maintained (AEE) at Buy with Decreased Target to $56 on, Jul 10th, 2017
[ 12:00 AM ] - WOPRAI
Stephen Byrd Maintained (AES) at Hold with Increased Target to $14 on, Jul 10th, 2017
[ 12:00 AM ] - WOPRAI
Mark Devries Initiated (AER) at Buy and Held Target at $61 on, Jul 10th, 2017
[ 12:00 AM ] - WOPRAI
Stephen Byrd Maintained (AEP) at Hold with Decreased Target to $71 on, Jul 10th, 2017
[ 12:00 AM ] - WOPRAI
David Lewis Maintained (ABT) at Hold with Increased Target to $49 on, Jul 10th, 2017
[ 12:00 AM ] - WOPRAI
Steve Beuchaw Maintained (A) at Buy with Increased Target to $75 on, Jul 10th, 2017
[ 12:00 AM ] - WOPRAI
Chris Kotowski Maintained (BAC) at Buy with Increased Target to $29 on, Jul 10th, 2017
[ 12:00 AM ] - WOPRAI
Howard Rubel Maintained (BA) at Strong Buy with Increased Target to $230 on, Jul 10th, 2017
[ 12:00 AM ] - WOPRAI
Peter Arment Maintained (BA) at Buy with Increased Target to $240 on, Jul 10th, 2017
[ 12:00 AM ] - WOPRAI
Richard Anderson Upgraded (BDN) to Strong Buy on, Jul 10th, 2017
[ 12:00 AM ] - WOPRAI
Matthew Harrison Maintained (BIIB) at Hold with Decreased Target to $301 on, Jul 10th, 2017
[ 12:00 AM ] - WOPRAI
David Lebovitz Maintained (ALNY) at Hold with Increased Target to $46 on, Jul 10th, 2017

David Lebovitz Maintained (ALNY) at Hold with Increased Target to $46 on, Jul 10th, 2017


Published on 2024-10-25 21:32:25 - WOPRAI, David Lebovitz
  Print publication without navigation


David Lebovitz of Morgan Stanley, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Hold with Increased Target from $42 to $46 on, Jul 10th, 2017.

David has made no other calls on ALNY in the last 4 months.



There are 2 other peers that have a rating on ALNY. Out of the 2 peers that are also analyzing ALNY, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Esther Rajavelu of "UBS" Initiated at Hold and Held Target at $55 on, Thursday, March 30th, 2017


This is the rating of the analyst that currently disagrees with David

  • Do Kim of "BMO Capital" Initiated at Buy and Held Target at $73 on, Monday, April 17th, 2017
Contributing Sources